Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new study just published in the Journal of General Internal Medicine makes a strong case for the importance of individualized application of specific treatments to older men diagnosed with prostate cancer — something which you would think ought to be evident to the majority of clinicians, but apparently wasn’t
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Co-morbidity, Diagnosis, Management, mortality, prognosis, risk | Leave a Comment »
New data from Peter Albertsen and his colleagues at the University of Connecticut have emphasized the importance of thorough assessment of the health status and co-morbidities of older men who are diagnosed with prostate cancer before making decisions about appropriate management.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: age, Co-morbidity, mortality | Leave a Comment »
In recent years, it has become increasingly well understood that patients diagnosed with low-risk prostate cancer are potentially susceptible to over-treatment. This is particularly the case among men who have significant degrees of co-morbidity and men greater than 75 years of age who have a life expectancy of < 15 years.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Charlson score, Co-morbidity, low risk, over-treatment, risk | Leave a Comment »
At the beginning of November, we commented on a re-analysis of the PLCO data by Crawford et al. — a re-analysis that focused on the impact of co-morbidities on treatment and outcomes over time.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Co-morbidity, early detection, localized, low risk, Management, screening | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site